305 related articles for article (PubMed ID: 22949088)
1. Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.
Regelmann WE; Schechter MS; Wagener JS; Morgan WJ; Pasta DJ; Elkin EP; Konstan MW;
Pediatr Pulmonol; 2013 Jul; 48(7):649-57. PubMed ID: 22949088
[TBL] [Abstract][Full Text] [Related]
2. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site.
Schechter MS; Regelmann WE; Sawicki GS; Rasouliyan L; VanDevanter DR; Rosenfeld M; Pasta D; Morgan W; Konstan MW
Pediatr Pulmonol; 2015 May; 50(5):431-40. PubMed ID: 25530325
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary outcome prediction (POP) tools for cystic fibrosis patients.
VanDevanter DR; Wagener JS; Pasta DJ; Elkin E; Jacobs JR; Morgan WJ; Konstan MW
Pediatr Pulmonol; 2010 Dec; 45(12):1156-66. PubMed ID: 20717915
[TBL] [Abstract][Full Text] [Related]
5. Course of Illness after Viral Infection in Indian Children with Cystic Fibrosis.
Gulla KM; Balaji A; Mukherjee A; Jat KR; Sankar J; Lodha R; Kabra SK
J Trop Pediatr; 2019 Apr; 65(2):176-182. PubMed ID: 29893951
[TBL] [Abstract][Full Text] [Related]
6. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary exacerbations in cystic fibrosis.
Rabin HR; Butler SM; Wohl ME; Geller DE; Colin AA; Schidlow DV; Johnson CA; Konstan MW; Regelmann WE;
Pediatr Pulmonol; 2004 May; 37(5):400-6. PubMed ID: 15095322
[TBL] [Abstract][Full Text] [Related]
8. Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis.
Rayment JH; Stanojevic S; Davis SD; Retsch-Bogart G; Ratjen F
Thorax; 2018 May; 73(5):451-458. PubMed ID: 29449440
[TBL] [Abstract][Full Text] [Related]
9. Rhinovirus-associated pulmonary exacerbations show a lack of FEV1 improvement in children with cystic fibrosis.
Cousin M; Molinari N; Foulongne V; Caimmi D; Vachier I; Abely M; Chiron R
Influenza Other Respir Viruses; 2016 Mar; 10(2):109-12. PubMed ID: 26493783
[TBL] [Abstract][Full Text] [Related]
10. Approach to treating cystic fibrosis pulmonary exacerbations varies widely across US CF care centers.
Kraynack NC; Gothard MD; Falletta LM; McBride JT
Pediatr Pulmonol; 2011 Sep; 46(9):870-81. PubMed ID: 21465675
[TBL] [Abstract][Full Text] [Related]
11. Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis.
Wagener JS; Rasouliyan L; VanDevanter DR; Pasta DJ; Regelmann WE; Morgan WJ; Konstan MW;
Pediatr Pulmonol; 2013 Jul; 48(7):666-73. PubMed ID: 22888106
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic duration and changes in FEV
Espel JC; Palac HL; Cullina JF; Clarke AP; McColley SA; Prickett MH; Jain M
BMC Pulm Med; 2017 Nov; 17(1):160. PubMed ID: 29187171
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosis.
McColley SA; Ren CL; Schechter MS; Regelmann WE; Pasta DJ; Konstan MW;
Pediatr Pulmonol; 2012 Oct; 47(10):966-72. PubMed ID: 22359344
[TBL] [Abstract][Full Text] [Related]
14. The impact of respiratory tract infections on the nutritional state of children with cystic fibrosis.
Trandafir LM; Moscalu M; Diaconu G; Cîrdeiu E; Tudose AA; Coman G; Păduraru DT
Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):863-9. PubMed ID: 24502062
[TBL] [Abstract][Full Text] [Related]
15. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.
Sanders DB; Solomon GM; Beckett VV; West NE; Daines CL; Heltshe SL; VanDevanter DR; Spahr JE; Gibson RL; Nick JA; Marshall BC; Flume PA; Goss CH;
J Cyst Fibros; 2017 Sep; 16(5):592-599. PubMed ID: 28460885
[TBL] [Abstract][Full Text] [Related]
16. Zinc Supplementation for One Year Among Children with Cystic Fibrosis Does Not Decrease Pulmonary Infection.
Sharma G; Lodha R; Shastri S; Saini S; Kapil A; Singla M; Mukherjee A; Jat KR; Kabra M; Kabra SK
Respir Care; 2016 Jan; 61(1):78-84. PubMed ID: 26443019
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
Schmitt-Grohé S; Zielen S
Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary exacerbations in CF patients with early lung disease.
Anstead M; Saiman L; Mayer-Hamblett N; Lands LC; Kloster M; Goss CH; Rose L; Burns JL; Marshall B; Ratjen F
J Cyst Fibros; 2014 Jan; 13(1):74-9. PubMed ID: 24029220
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.
Zemanick ET; Wagner BD; Harris JK; Wagener JS; Accurso FJ; Sagel SD
Pediatr Pulmonol; 2010 Jun; 45(6):569-77. PubMed ID: 20503282
[TBL] [Abstract][Full Text] [Related]
20. Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis.
Pamukcu A; Bush A; Buchdahl R
Pediatr Pulmonol; 1995 Jan; 19(1):10-5. PubMed ID: 7675552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]